Physiology and pathophysiology of iron in hemoglobin-associated diseases

Free Radic Biol Med. 2014 Jul:72:23-40. doi: 10.1016/j.freeradbiomed.2014.03.039. Epub 2014 Apr 12.

Abstract

Iron overload and iron toxicity, whether because of increased absorption or iron loading from repeated transfusions, can be major causes of morbidity and mortality in a number of chronic anemias. Significant advances have been made in our understanding of iron homeostasis over the past decade. At the same time, advances in magnetic resonance imaging have allowed clinicians to monitor and quantify iron concentrations noninvasively in specific organs. Furthermore, effective iron chelators are now available, including preparations that can be taken orally. This has resulted in substantial improvement in mortality and morbidity for patients with severe chronic iron overload. This paper reviews the key points of iron homeostasis and attempts to place clinical observations in patients with transfusional iron overload in context with the current understanding of iron homeostasis in humans.

Keywords: Chelation; Hemochromatosis; Hemoglobinopathy; Iron overload; Iron toxicity; Magnetic resonance imaging; ROS; Sickle cell disease; Thalassemia; Transfusion.

Publication types

  • Review

MeSH terms

  • Hemoglobinopathies / drug therapy
  • Hemoglobinopathies / metabolism
  • Hemoglobinopathies / physiopathology*
  • Hemoglobins / metabolism
  • Homeostasis / physiology*
  • Humans
  • Iron / metabolism*
  • Iron Chelating Agents / therapeutic use
  • Iron Overload / physiopathology

Substances

  • Hemoglobins
  • Iron Chelating Agents
  • Iron